Avoiding Polypharmacy & Topical Confusion with Roflumilast

Dr. Ted Lain welcomes Dr. Mona Shariari — Associate Clinical Professor of Dermatology at Yale School of Medicine, Associate Director of Clinical Trials at Central Connecticut Dermatology, and host of the Medical Sisterhood Podcast — for a deep dive into one of dermatology's most persistent challenges: polypharmacy and topical confusion.Ted and Mona look back at the old-school regimens dermatologists used to write out — one topical for the face, another for the body, different products for weekdays versus weekends — and how that complexity set patients up for poor adherence and side effects like skin thinning and hypopigmentation from steroid overuse. They discuss why once-daily, non-steroidal options like roflumilast cream and foam have changed the equation, allowing head-to-toe use without the body surface area and duration limits that come with topical steroids.Got a question or an idea for a future episode? Email [email protected] us at the Science of Skin Summit in Austin, TX this September, and the Science of Skin Longevity Summit in Scottsdale, AZ in February 2027. Details at scienceofskinsummit.comIf you enjoyed this episode, please subscribe and leave a 5-star rating — word of mouth is how this podcast grows!Follow and Listen to the Podcast Here:🍎 Apple Podcasts — https://podcasts.apple.com/us/podcast/skincare-confidential/id1664286292🎵 Spotify — https://open.spotify.com/show/033Vffp4W8A72pVRVaoWzs📦 Amazon Music — https://music.amazon.com/podcasts/7de48e5e-f450-466b-a0f4-f2275b67757f/skincare-confidential💚 iHeart Radio — https://www.iheart.com/podcast/269-the-science-of-skin-269540115/📻 Audacy — https://www.audacy.com/podcast/skincare-confidential-4398f#Dermatology #Roflumilast #EczemaTreatment #PsoriasisTreatment #SeborrheicDermatitis #AtopicDermatitis #TopicalSteroids #SteroidStewardship #NonSteroidalTreatment #PediatricDermatology #DermatologyPodcast #ScienceOfSkin #YaleDermatology #SkinHealth